- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06388655
The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent
The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent Participants: a Randomized Sham-control Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nam-gu
-
Daegu, Nam-gu, Korea, Republic of, 42471
- Daegu Catholic University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Child participants ranging from 8 to 15 years of age, who were recruited from the Department of Psychiatry at Daegu Catholic University Medical Center between 2019 and 2021
Exclusion Criteria:
History of congenital genetic diseases History of brain damage History of neurological disorders History of psychiatric conditions such as schizophrenia spectrum disorder, autism spectrum disorder, obsessive-compulsive disorder, major depressive disorder, or bipolar disorder Participants with an IQ below 70, as determined by the Korean-Wechsler Intelligence Scale for Children-Fourth Edition (K-WISC-IV)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MNF active group
In this study, neurofeedback headsets developed by OmniCNS were utilized, employing a dry EEG method to measure EEG signals at a rate of 250Hz.
Signals were then transformed into the frequency domain through Fourier transform, allowing assessment of power across a wide range of frequencies.
Feedback activities, like levitation or running, were based on attention levels determined by the Low beta + Middle beta / Theta Power ratio.
Participants received training and engaged in neurofeedback games through the Omnifit Brain app using the provided headsets and personal smartphones for 12 weeks, three times a week for 10-20 minutes per session.
Four game types based on the theta/beta ratio were offered, allowing participants to choose freely.
|
The participants were randomly assigned to the MNF active (N=31) or sham control (N=30) groups.
The MNF program was administered using a mobile app (equipped with a headset with a 2-channel EEG sensor) for 30 min/day, 3 days/week, for 3 months.
|
|
Sham Comparator: sham control group
The sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements.
The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.
|
The sham neurofeedback was implemented through presenting randomized game outcomes, independent of real measurements.
The scoring distribution was meticulously adjusted to achieve a realistic spectrum of results, prioritizing median scores to uphold uniformity in user experience.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparisons of the means of children's self-scale variables
Time Frame: through study completion, an average of 1 year
|
Participants' condition regarding internet addiction, among other factors, was assessed using children's self-scales such as the Korea Internet Addiction Scale (K-scale).
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparisons of the means of parents' self-scale variables : Beck Depression Inventory-II (BDI-II)
Time Frame: through study completion, an average of 1 year
|
The evaluation of participants was conducted using parents' self-scales : Beck Depression Inventory-II (BDI-II)
|
through study completion, an average of 1 year
|
|
Comparisons of the means of parents' self-scale variables : Beck Anxiety Inventory (BAI)
Time Frame: through study completion, an average of 1 year
|
The evaluation of participants was conducted using parents' self-scales : Beck Anxiety Inventory (BAI)
|
through study completion, an average of 1 year
|
|
Comparisons of the means of children's K-WISC-IV(Korean Wechsler Intelligence Scale for Children-IV)
Time Frame: through study completion, an average of 1 year
|
Participants' intelligence levels were assessed using measures
|
through study completion, an average of 1 year
|
|
Comparisons of the means of children's Stroop
Time Frame: through study completion, an average of 1 year
|
Participants' attention levels were assessed using measures
|
through study completion, an average of 1 year
|
|
Comparisons of the means of children's ATA(Advanced Test of Attention)
Time Frame: through study completion, an average of 1 year
|
Participants' attention levels were assessed using measures
|
through study completion, an average of 1 year
|
|
Comparisons of the means of children's CCTT(Children's Color Trails Test)
Time Frame: through study completion, an average of 1 year
|
Participants' attention levels were assessed using measures
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MDCR-19-007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Internet Addiction
-
Istanbul Saglik Bilimleri UniversityIstanbul University - CerrahpasaRecruitingInternet Gaming Disorder | Internet AddictionTurkey (Türkiye)
-
Mersin UniversityÇankırı Karatekin University; Scientific and Technological Research Council...CompletedInternet Addiction | Smartphone Addiction | Technology AddictionTurkey (Türkiye)
-
Akdeniz UniversityCompletedInternet Addiction | Problematic Internet Use | Healthy Internet UseTurkey (Türkiye)
-
Assiut UniversityNot yet recruitingInternet Gaming Disorder | Internet Addiction
-
Zagazig UniversityActive, not recruitingInternet Addiction | Gaming Disorder | Porn AddictionEgypt
-
Chengdu Sport UniversityNot yet recruitingInternet Addiction Disorder
-
The Hong Kong Polytechnic UniversityRecruiting
-
Gazi UniversityCompletedInternet Addiction | Game Addiction, VideoTurkey
-
Gazi UniversityCompletedInternet Addiction Level | Perceived Stres Level | Social Skill LevelTurkey
-
Artvin Coruh UniversityRecruitingParenting | Social Media Addiction | Internet AddictionTurkey
Clinical Trials on mobile neurofeedback
-
Seoul National University Childrens HospitalHanyang University; Wonkwang University HospitalUnknownAttention Deficit Hyperactivity DisorderKorea, Republic of
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedChronic Pain | Posttraumatic Stress Disorders | Traumatic Brain InjuryUnited States
-
CrossComm, Inc.National Institute on Drug Abuse (NIDA); Duke UniversityActive, not recruitingChronic Pain | Opioid UseUnited States
-
University of Rhode IslandCompletedNeurofeedbackUnited States
-
Kowloon Hospital, Hong KongChinese University of Hong KongCompletedStroke | Cognitive ImpairmentHong Kong
-
Sheba Medical CenterMyndlift Ltd.UnknownAttention Deficit Hyperactivity Disorder
-
University of OxfordWellcome TrustTerminated
-
ETH ZurichSwiss Epilepsy Centre - Klinik LenggRecruitingHealth, Subjective | Epilepsy, Temporal Lobe | Psychogenic SeizureSwitzerland
-
Laureate Institute for Brain Research, Inc.National Institute of General Medical Sciences (NIGMS)TerminatedDepressive Disorder, MajorUnited States
-
PD Dr. med. Margret Hund-GeorgiadisSwiss Tropical & Public Health Institute; Rehab BaselCompleted